نتایج جستجو برای: methylphenidate mph

تعداد نتایج: 6344  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Donald R Mattison Tony M Plant Hui-Min Lin Hung-Chia Chen James J Chen Nathan C Twaddle Daniel Doerge William Slikker Ralph E Patton Charlotte E Hotchkiss Ralph J Callicott Steven M Schrader Terry W Turner James S Kesner Benedetto Vitiello Dayton M Petibone Suzanne M Morris

Juvenile male rhesus monkeys treated with methylphenidate hydrochloride (MPH) to evaluate genetic and behavioral toxicity were observed after 14 mo of treatment to have delayed pubertal progression with impaired testicular descent and reduced testicular volume. Further evaluation of animals dosed orally twice a day with (i) 0.5 mL/kg of vehicle (n = 10), (ii) 0.15 mg/kg of MPH increased to 2.5 ...

Journal: :European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2007
Esther H H Keulers Jos G M Hendriksen Frans J M Feron Renske Wassenberg Mea G F Wuisman-Frerker Jelle Jolles Johan S H Vles

Attention Deficit Hyperactivity Disorder (ADHD) and dyslexia are frequently co-occurring disorders. Although methylphenidate (MPH) is the primary treatment for ADHD, the effect on reading in children with these comorbid problems is not yet known. This study was an unblinded clinical trial to evaluate the reading performance before and after treatment with MPH. Reading performance was compared w...

Journal: :Neuropsychologia 2008
Katherine A Johnson Edwina Barry Mark A Bellgrove Marie Cox Simon P Kelly Aoife Dáibhis Michael Daly Michelle Keavey Amy Watchorn Michael Fitzgerald Fiona McNicholas Aiveen Kirley Ian H Robertson Michael Gill

Increased variability in reaction time (RT) has been proposed as a cardinal feature of attention deficit hyperactivity disorder (ADHD). Increased variability during sustained attention tasks may reflect inefficient fronto-striatal and fronto-parietal circuitry; activity within these circuits is modulated by the catecholamines. A disruption to dopamine signaling is suggested in ADHD that may be ...

Journal: :Research in developmental disabilities 2010
Orit Bart Tamar Podoly Yair Bar-Haim

Attention Deficit Hyperactive Disorder (ADHD) and Developmental Coordination Disorder (DCD) are two developmental disorders with considerable comorbidity. The impact of Methylphenidate (MPH) on ADHD symptoms is well documented. However, the effects of MPH on motor coordination are less studied. We assessed the influence of MPH on motor performance of children with comorbid DCD and ADHD. Partici...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2010
Rita Z Goldstein Patricia A Woicik Thomas Maloney Dardo Tomasi Nelly Alia-Klein Juntian Shan Jean Honorio Dimitris Samaras Ruiliang Wang Frank Telang Gene-Jack Wang Nora D Volkow

Anterior cingulate cortex (ACC) hypoactivations during cognitive demand are a hallmark deficit in drug addiction. Methylphenidate (MPH) normalizes cortical function, enhancing task salience and improving associated cognitive abilities, in other frontal lobe pathologies; however, in clinical trials, MPH did not improve treatment outcome in cocaine addiction. We hypothesized that oral MPH will at...

Journal: :The journals of gerontology. Series A, Biological sciences and medical sciences 2013
Zamir Shorer Yaakov Bachner Tal Guy Itshak Melzer

BACKGROUND Methylphenidate (MPH) action may improve executive function and motor function. Effects of MPH on balance function in older adults were investigated. METHODS A randomized controlled double-blind study examined the effects of a single dose of MPH on gait and postural stability in 30 healthy older adults (mean age = 74.9 ± 5.6) in four task conditions: (a) single task, standing still...

Journal: :Neurobiology of learning and memory 2013
Kimberly R Urban Yan-Chun Li Wen-Jun Gao

Methylphenidate (Ritalin, MPH) is the most commonly prescribed psychoactive drug for children. Used to treat attention-deficit/hyperactivity disorder (ADHD) and for cognitive enhancement in healthy individuals, its cellular mechanisms of action and potential long-term effects are poorly understood. We recently reported that a clinically relevant (1 mg/kg i.p., single injection) dose of MPH sign...

Journal: :Advances in therapy 2007
T Fikret Ilgenli Ayhan Congologlu Cengiz Ozturk Tumer Turkbay Onur Akpinar Fethi Kilicaslan

Among childhood psychiatric disorders, attention deficit hyperactivity disorder (ADHD) is of greatest interest to practitioners. Methylphenidate (MPH) is a drug that is widely used in the treatment of children in whom ADHD has been diagnosed. Although this treatment has been used for years, its effects on the heart remain the subject of debate. The QT interval comprises the ventricular activati...

Journal: :Psychological medicine 2016
H G H Tamminga L Reneman H M Huizenga H M Geurts

Attention-deficit/hyperactivity disorder (ADHD) in childhood and adulthood is often treated with the psychostimulant methylphenidate (MPH). However, it is unknown whether cognitive effects of MPH depend on age in individuals with ADHD, while animal studies have suggested age-related effects. In this meta-analysis, we first determined the effects of MPH on response inhibition, working memory and...

Journal: :Cerebral cortex 2013
Anna Costa Michael Riedel Oliver Pogarell Frank Menzel-Zelnitschek Markus Schwarz Maximilian Reiser Hans-Jürgen Möller Katya Rubia Thomas Meindl Ulrich Ettinger

Methylphenidate (MPH) is a catecholamine transporter blocker, with dopamine agonistic effects in the basal ganglia. Response inhibition, error detection, and its mediating frontostriatal brain activation are improved by MPH in patients with attention-deficit/hyperactivity disorder. However, little is known about the effects of MPH on response inhibition and error processing or its underlying br...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید